|4Jan 19, 6:21 PM ET

MORNEAU MICHAEL 4

4 · Viking Therapeutics, Inc. · Filed Jan 19, 2021

Insider Transaction Report

Form 4
Period: 2021-01-19
MORNEAU MICHAEL
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock, par value $0.00001 per share

    2021-01-19$6.68/sh1,685$11,256116,062 total
Footnotes (1)
  • [F1]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION